Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-787 in Adult Volunteers Experimentally Inoculated with Live Influenza A Virus
2011-005929-49Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing VX-787 with Placebo (2 arms). Primary endpoint: Viral AUC (cell culture of nasal swabs). Started Feb 2012; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2011-005929-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005929-49.